The Clinical Development Team at Immix Biopharma is responsible for designing, planning, and overseeing clinical trials to evaluate the safety and efficacy of Tissue-Specific Therapeutics (TSTx)™. This includes developing clinical protocols, managing trial logistics, ensuring regulatory compliance, and coordinating between various stakeholders to advance oncology and inflammation therapies through the clinical pipeline.